Sign In
Buy AXSM
$233.49
+11.33 (+5.10%)
At Close: Jun 03, 2026
3 Monster Stocks in the Making to Buy Right Now
06:07am, Sunday, 25'th Jun 2023
Axsome Therapeutics' pipeline features multiple potentially big winners. CRISPR Therapeutics could be at the beginning of a long-term success story.
3 Biotech Stocks to Buy as Companies Ink Major Deals
06:40am, Thursday, 22'nd Jun 2023
With patent expirations around the corner, some of the biggest pharmaceutical and biotech companies will soon face generic competition, creating a big opportunity for these top biotech stocks to buy.
Where Will Axsome Therapeutics Be in 3 Years?
08:23am, Tuesday, 20'th Jun 2023
Axsome's two new products are seeing prescription growth. The company aims to launch four more products in just a couple of years.
This Stock Crushed the Market Last Year. Here's Why It Could Do That Again.
02:00pm, Friday, 16'th Jun 2023
Axsome Therapeutics shares soared more than 100% last year after its first two products launched. It may have more on the way.
Axsome (AXSM) Soars 8.1%: Is Further Upside Left in the Stock?
04:01am, Thursday, 15'th Jun 2023
Axsome (AXSM) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
3 No-Brainer Stocks to Buy in June
06:14am, Saturday, 10'th Jun 2023
Axsome Therapeutics is a rising star in biotech. Pfizer is too cheap to pass up.
The Top Healthcare Stocks to Buy With $100
02:00pm, Friday, 09'th Jun 2023
Teladoc and Axsome offer solid growth potential and are in the early days of their growth stories. Pfizer offers passive income while investors wait for this pharma-giant's new phase of growth to begi
Why Is Axsome (AXSM) Down 2.5% Since Last Earnings Report?
12:34pm, Wednesday, 07'th Jun 2023
Axsome (AXSM) reported earnings 30 days ago. What's next for the stock?
Axsome Therapeutics to Present New Sunosi® Data at SLEEP 2023
07:00am, Thursday, 01'st Jun 2023
Cognitive improvement with Sunosi sustained over eight hours in patients with excessive daytime sleepiness due to obstructive sleep apnea Cognitive improvement with Sunosi sustained over eight hours i
Data on Auvelity demonstrating improved functioning in major depressive disorder Data on Sunosi demonstrating improved cognitive function in patients with excessive daytime sleepiness associated with
Prediction: These 2 Stocks Could Double In the Next Year
10:15am, Sunday, 28'th May 2023
CRISPR Therapeutics is awaiting approval for a potential multi-billion product. Axsome Therapeutics has several clinical and regulatory milestones ahead.
2 Biotech Stocks That Could Help Set You Up for Life
09:37am, Friday, 26'th May 2023
Axsome has two approved treatments as well as candidates in late-stage development Vertex has the dominant treatment for cystic fibrosis and is developing other products.
2 Bear Market Defying Stocks to Buy in May
07:45am, Monday, 22'nd May 2023
Sanofi's wide lineup of medicines across several therapeutic areas makes it attractive. Axsome Therapeutics is rising in prominence thanks to an exciting pipeline.
2 Unstoppable Growth Stocks to Buy in 2023 and Beyond
09:30am, Saturday, 20'th May 2023
Axsome has several catalysts in the works that could boost its stock price. Exelixis is working on new drugs to expand its footprint in oncology.
Is a Victory for Its Rivals Bad News for Axsome Therapeutics?
05:30am, Wednesday, 17'th May 2023
The partnership of Otsuka Pharmaceutical and Lundbeck beat Axsome to market with the first approved treatment for Alzheimer's disease agitation. Axsome reported strong clinical trail data from its can
